PSMA PET and radiomics for the evaluation of liver metastases in castration-resistant prostate cancer patients: a multicenter retrospective study

被引：0

作者：

Mattoni, S. ^{[1
]}

Formaggio, F. ^{[1
]}

Bruno, G. ^{[2
]}

Caroli, P. ^{[3
]}

Cerci, J. ^{[4
]}

Eiber, M. ^{[5
]}

Fendler, W. ^{[6
]}

Golfieri, R. ^{[7
]}

Herrmann, K. ^{[6
]}

Matteucci, F. ^{[3
]}

Mosconi, C. ^{[7
]}

Paolani, G. ^{[8
]}

Santoro, M. ^{[8
]}

Strigari, L. ^{[8
]}

Nanni, C. ^{[1
]}

Castellucci, P. ^{[1
]}

Fanti, S. ^{[1
]}

Farolfi, A. ^{[1
]}

机构：

[1] Univ Bologna, Div Nucl Med, IRCCS Azienda Osped, Bologna, Italy

[2] Fdn Ctr Diagnost Nucl FCDN, Buenos Aires, DF, Argentina

[3] Ist Sci Romagnolo Studio Cura Tumori Dino Amadori, Dept Nucl Med, Meldola, Italy

[4] Quanta Diagnost & Terapia, Dept Nucl Med, Curitiba, Parana, Brazil

[5] Tech Univ Munich TUM, Dept Nucl Med, Klinikum Rechts Isar, Munich, Germany

[6] Univ Duisburg Essen, Dept Nucl Med, Essen, Germany

[7] Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany

[8] IRCCS Azienda Osped Univ Bologna, Dept Radiol, Bologna, Italy

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

OP-0655

引用

页码：S234 / S234

页数：1

共 50 条

[31] ECF chemotherapy for liver metastases due to castration-resistant prostate cancer (mCRPC)
Gupta, S.
Potvin, K. R.
Whiston, F.
Winquist, E.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
[32] Isolated Adrenal Metastases of Castration-Resistant Prostate Cancer
Topal, Edanur
Has Simsek, Duygu
Vatansever, Sezai
Sanli, Yasemin
Kuyumcu, Serkan
CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : E8 - E9
[33] Pain in castration-resistant prostate cancer with bone metastases: a qualitative study
Adam Gater
Linda Abetz-Webb
Clare Battersby
Bhash Parasuraman
Stuart McIntosh
Faith Nathan
Elisabeth C Piault
Health and Quality of Life Outcomes, 9
[34] Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer
Michaelson, M. D.
Bellmunt, J.
Hudes, G. R.
Goel, S.
Lee, R. J.
Kantoff, P. W.
Stein, C. A.
Lardelli, P.
Pardos, I.
Kahatt, C.
Nieto, A.
Cullell-Young, M.
Lewis, N. L.
Smith, M. R.
ANNALS OF ONCOLOGY, 2012, 23 (05) : 1234 - 1240
[35] Pain in castration-resistant prostate cancer with bone metastases: a qualitative study
Gater, Adam
Abetz-Webb, Linda
Battersby, Clare
Parasuraman, Bhash
McIntosh, Stuart
Nathan, Faith
Piault, Elisabeth C.
HEALTH AND QUALITY OF LIFE OUTCOMES, 2011, 9
[36] Evaluation of Nephrotoxicity of Extended Lu177-PSMA in Patients with Metastatic Castration-Resistant Prostate Cancer
Topal, E.
Kovan, B.
Simsek, D. Has
Civan, C.
Sanli, M.
Basaran, M.
Sanli, Y.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S151 - S152
[37] Response and Tolerability of a Single Dose of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis
Rahbar, Kambiz
Schmidt, Matthias
Heinzel, Alexander
Eppard, Elisabeth
Bode, Axel
Yordanova, Anna
Claesener, Michael
Ahmadzadehfar, Hojjat
JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (09) : 1334 - 1338
[38] PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer
Hope, Thomas A.
Calais, Jeremie
LANCET, 2021, 397 (10276): : 768 - 769
[39] Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
Gutsche, Robin
Guelmues, Gizem
Mottaghy, Felix M.
Gaertner, Florian
Essler, Markus
von Mallek, Dirk
Ahmadzadehfar, Hojjat
Lohmann, Philipp
Heinzel, Alexander
FRONTIERS IN NUCLEAR MEDICINE, 2023, 3
[40] Treatment of Multiple Bone Metastases of Castration-Resistant Prostate Cancer With 225Ac-PSMA-617
Yang, Hongyu
Zhang, Yu
Su, Dan
Chen, Yue
CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : 1078 - 1081

← 1 2 3 4 5 →